2025年北美放射学会(RSNA)年会于当地时间11月30日—12月4日在美国芝加哥举行。本届大会以“影现个体:以多元、公平、包容,照见精准医疗未来”(Imaging the Individual:Precision Health through Diversity, Equity and Inclusion)为主...2025年北美放射学会(RSNA)年会于当地时间11月30日—12月4日在美国芝加哥举行。本届大会以“影现个体:以多元、公平、包容,照见精准医疗未来”(Imaging the Individual:Precision Health through Diversity, Equity and Inclusion)为主题,将精准医疗从纯粹的技术追求,延伸至确保技术成果能公平、包容地惠及每一个独特个体的社会实践。展开更多
Background: Vaccines remain the only viable and safe option to control transmission and minimise disease sequelae during the COVID-19 pandemic. Whilst multiple vaccines are available, evidence has emerged regarding th...Background: Vaccines remain the only viable and safe option to control transmission and minimise disease sequelae during the COVID-19 pandemic. Whilst multiple vaccines are available, evidence has emerged regarding the association between the ChAdOx1 nCoV-19 vaccine, platelets and thrombosis, manifesting in thrombotic thrombocytopaenia. Case Summary: We report a case of recurrent coronary artery thrombosis on triple antithrombotic therapy, namely aspirin, clopidogrel, and continuous intravenous heparin, nine days after the ChAdOx1 nCoV-19 vaccine, in a 63-year-old female with no significant history of cardiovascular disease. Conclusion: This case may suggest that the association between platelets, SARS-CoV-2, the ChAdOx1 nCoV-19 vaccine, and coronary thrombosis may remain incompletely understood and warrants further study. Clinicians should remain on high alert if presented with similar circumstances.展开更多
文摘2025年北美放射学会(RSNA)年会于当地时间11月30日—12月4日在美国芝加哥举行。本届大会以“影现个体:以多元、公平、包容,照见精准医疗未来”(Imaging the Individual:Precision Health through Diversity, Equity and Inclusion)为主题,将精准医疗从纯粹的技术追求,延伸至确保技术成果能公平、包容地惠及每一个独特个体的社会实践。
文摘Background: Vaccines remain the only viable and safe option to control transmission and minimise disease sequelae during the COVID-19 pandemic. Whilst multiple vaccines are available, evidence has emerged regarding the association between the ChAdOx1 nCoV-19 vaccine, platelets and thrombosis, manifesting in thrombotic thrombocytopaenia. Case Summary: We report a case of recurrent coronary artery thrombosis on triple antithrombotic therapy, namely aspirin, clopidogrel, and continuous intravenous heparin, nine days after the ChAdOx1 nCoV-19 vaccine, in a 63-year-old female with no significant history of cardiovascular disease. Conclusion: This case may suggest that the association between platelets, SARS-CoV-2, the ChAdOx1 nCoV-19 vaccine, and coronary thrombosis may remain incompletely understood and warrants further study. Clinicians should remain on high alert if presented with similar circumstances.
